CENSA PHARMACEUTICALS
Summary
Censa Pharmaceuticals is a biopharmaceutical company focused on the development of CNSA-001 (sepiapterin), a clinical-stage investigational therapy for orphan metabolic diseases.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 208 M
Avg. Deal Size£ 208 M
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
